Anton Turanov

Title: Innovations of Anton Turanov

Introduction

Anton Turanov is an accomplished inventor based in Revere, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of inhibiting LPA expression. With a total of three patents to his name, Turanov's work has the potential to impact the treatment of various diseases and disorders.

Latest Patents

Turanov's latest patents focus on compositions and methods for inhibiting LPA expression. The patents detail oligonucleotides that inhibit apolipoprotein(a) (LPA) expression. These compositions are designed for use in treating diseases, disorders, and conditions associated with LPA expression. The innovative nature of these patents highlights Turanov's commitment to advancing medical science.

Career Highlights

Anton Turanov is currently employed at Dicerna Pharmaceuticals, Inc., where he continues to develop groundbreaking solutions in the biotechnology sector. His work at Dicerna has positioned him as a key player in the field, contributing to the company's mission of improving patient outcomes through innovative therapies.

Collaborations

Turanov collaborates with notable colleagues, including Bob Dale Brown and Henryk T Dudek. These partnerships enhance the research and development efforts at Dicerna Pharmaceuticals, fostering an environment of innovation and creativity.

Conclusion

Anton Turanov's contributions to biotechnology through his patents and work at Dicerna Pharmaceuticals exemplify the impact of innovation in medicine. His ongoing research promises to lead to significant advancements in the treatment of conditions related to LPA expression.